150 related articles for article (PubMed ID: 38280477)
1. Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine.
Shin D; Lee J; Roh JL
Cancer Lett; 2024 Mar; 585():216645. PubMed ID: 38280477
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis as a p53-mediated activity during tumour suppression.
Jiang L; Kon N; Li T; Wang SJ; Su T; Hibshoosh H; Baer R; Gu W
Nature; 2015 Apr; 520(7545):57-62. PubMed ID: 25799988
[TBL] [Abstract][Full Text] [Related]
3. Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses.
Jiang L; Hickman JH; Wang SJ; Gu W
Cell Cycle; 2015; 14(18):2881-5. PubMed ID: 26218928
[TBL] [Abstract][Full Text] [Related]
4. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.
Tarangelo A; Magtanong L; Bieging-Rolett KT; Li Y; Ye J; Attardi LD; Dixon SJ
Cell Rep; 2018 Jan; 22(3):569-575. PubMed ID: 29346757
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53.
Wang Y; Yang L; Zhang X; Cui W; Liu Y; Sun QR; He Q; Zhao S; Zhang GA; Wang Y; Chen S
EMBO Rep; 2019 Jul; 20(7):e47563. PubMed ID: 31267712
[TBL] [Abstract][Full Text] [Related]
6. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis.
Gnanapradeepan K; Basu S; Barnoud T; Budina-Kolomets A; Kung CP; Murphy ME
Front Endocrinol (Lausanne); 2018; 9():124. PubMed ID: 29695998
[TBL] [Abstract][Full Text] [Related]
7. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
[TBL] [Abstract][Full Text] [Related]
8. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
[TBL] [Abstract][Full Text] [Related]
9. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
10. p53: A double-edged sword in tumor ferroptosis.
Ji H; Wang W; Li X; Han X; Zhang X; Wang J; Liu C; Huang L; Gao W
Pharmacol Res; 2022 Mar; 177():106013. PubMed ID: 34856333
[TBL] [Abstract][Full Text] [Related]
11. P53 together with ferroptosis: a promising strategy leaving cancer cells without escape.
Zhan J; Wang J; Liang Y; Zeng X; Li E; Wang H
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):1-14. PubMed ID: 38105650
[TBL] [Abstract][Full Text] [Related]
12. PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis.
Gnanapradeepan K; Indeglia A; Stieg DC; Clarke N; Shao C; Dougherty JF; Murali N; Murphy ME
J Biol Chem; 2022 Dec; 298(12):102637. PubMed ID: 36309086
[TBL] [Abstract][Full Text] [Related]
13. p53 in ferroptosis regulation: the new weapon for the old guardian.
Liu Y; Gu W
Cell Death Differ; 2022 May; 29(5):895-910. PubMed ID: 35087226
[TBL] [Abstract][Full Text] [Related]
14. Cytoglobin promotes sensitivity to ferroptosis by regulating p53-YAP1 axis in colon cancer cells.
Ye S; Xu M; Zhu T; Chen J; Shi S; Jiang H; Zheng Q; Liao Q; Ding X; Xi Y
J Cell Mol Med; 2021 Apr; 25(7):3300-3311. PubMed ID: 33611811
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor protein p53 and the ferroptosis network.
Kang R; Kroemer G; Tang D
Free Radic Biol Med; 2019 Mar; 133():162-168. PubMed ID: 29800655
[TBL] [Abstract][Full Text] [Related]
16. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling.
Zeng C; Lin J; Zhang K; Ou H; Shen K; Liu Q; Wei Z; Dong X; Zeng X; Zeng L; Wang W; Yao J
Cancer Sci; 2022 Nov; 113(11):3766-3775. PubMed ID: 35968603
[TBL] [Abstract][Full Text] [Related]
17. miR-491-5p regulates the susceptibility of glioblastoma to ferroptosis through TP53.
Jie XF; Li YP; Liu S; Fu Y; Xiong YY
Biochem Biophys Res Commun; 2023 Sep; 671():309-317. PubMed ID: 37327702
[TBL] [Abstract][Full Text] [Related]
18. NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression.
Chen D; Tavana O; Chu B; Erber L; Chen Y; Baer R; Gu W
Mol Cell; 2017 Oct; 68(1):224-232.e4. PubMed ID: 28985506
[TBL] [Abstract][Full Text] [Related]
19. Sirt3 is critical for p53-mediated ferroptosis upon ROS-induced stress.
Jin Y; Gu W; Chen W
J Mol Cell Biol; 2021 May; 13(2):151-154. PubMed ID: 33377976
[No Abstract] [Full Text] [Related]
20. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
